Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 33, Pages 10304-10309
Publisher
Proceedings of the National Academy of Sciences
Online
2015-08-04
DOI
10.1073/pnas.1506684112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue-engineered models of human tumors for cancer research
- (2015) Aranzazu Villasante et al. Expert Opinion on Drug Discovery
- 3D tissue-engineered model of Ewing's sarcoma
- (2014) Salah-Eddine Lamhamedi-Cherradi et al. ADVANCED DRUG DELIVERY REVIEWS
- Bioengineered human tumor within a bone niche
- (2014) Aranzazu Villasante et al. BIOMATERIALS
- Biomimetic Tissue-Engineered Systems for Advancing Cancer Research: NCI Strategic Workshop Report
- (2014) T. K. Schuessler et al. CANCER RESEARCH
- MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas
- (2014) H. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination
- (2013) Jennifer N. Beck et al. BIOMATERIALS
- Development of an in Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer Drug
- (2013) Crystal S. Shin et al. MOLECULAR PHARMACEUTICS
- Insulin-Like Growth Factor I (IGF-1) Ec/Mechano Growth Factor – A Splice Variant of IGF-1 within the Growth Plate
- (2013) Werner Schlegel et al. PLoS One
- Modeling Ewing sarcoma tumors in vitro with 3D scaffolds
- (2013) E. L. S. Fong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanosensation and transduction in osteocytes
- (2012) Jenneke Klein-Nulend et al. BONE
- The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer
- (2012) Kenny Chitcholtan et al. Journal of Translational Medicine
- Design of a High-Throughput Flow Perfusion Bioreactor System for Tissue Engineering
- (2012) Rebecca L. Dahlin et al. TISSUE ENGINEERING PART C-METHODS
- A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2011) F. Atzori et al. CLINICAL CANCER RESEARCH
- Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance
- (2011) Joseph A. Ludwig et al. Cancers
- Influence of Shear Stress in Perfusion Bioreactor Cultures for the Development of Three-Dimensional Bone Tissue Constructs: A Review
- (2010) Ryan J. McCoy et al. TISSUE ENGINEERING PART B-REVIEWS
- Identification of Cancer Stem Cells in Ewing's Sarcoma
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Ewing’s Sarcoma: Standard and Experimental Treatment Options
- (2009) Vivek Subbiah et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The insulin-like growth factor system and sarcomas
- (2008) Bart Rikhof et al. JOURNAL OF PATHOLOGY
- Mechanotransduction in development: a growing role for contractility
- (2008) Michele A. Wozniak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanotransduction gone awry
- (2008) Diana E. Jaalouk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus
- (2008) Ning Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines
- (2008) P. Romano et al. NUCLEIC ACIDS RESEARCH
- IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
- (2008) Luisa Cironi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started